Insurance - Life Industry | Financial Services Sector | Ms. Wenxia Zhou CEO | XSHE Exchange | CNE000000F48 ISIN |
CN Country | 1,765 Employees | - Last Dividend | 12 Apr 2010 Last Split | 12 Nov 1996 IPO Date |
Hubei Biocause Pharmaceutical Co., Ltd. is a multifaceted enterprise based in Jingmen, China, with a primary focus on providing life and motor insurance products to the Chinese market. Beyond insurance, the company has diversified interests in the pharmaceutical, chemical, and new energy fuel sectors. The firm is engaged in both research and production activities across a variety of products and services. With an international footprint, Hubei Biocause Pharmaceutical exports its products to approximately 85 countries worldwide, including the United States and the European Union, showcasing its global reach and the diverse markets it serves.